Close

GlaxoSmithKline (GSK) Reports Q2 EPS of 21.2p; Revs Slip

July 24, 2013 7:14 AM EDT Send to a Friend
GlaxoSmithKline (NYSE: GSK) reported Q2 EPS of GBP0.21 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login